Skip to main content
OpenTrials

Clinical trial condition

Atopic Dermatitis

Explore clinical trials studying Atopic Dermatitis. Study availability and eligibility vary by location and protocol.

857 public trials 113 recruiting studies
Refine in advanced search Browse all conditions

Atopic Dermatitis trial results

Completed

An Evaluation of LEO 138559 in Adults With Moderate to Severe Atopic Dermatitis.

NCT04922021

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • LEO Pharma Investigational Site Birmingham, Alabama, United States
  • LEO Pharma Investigational Site Fountain Valley, California, United States
  • LEO Pharma Investigational Site Los Angeles, California, United States
  • LEO Pharma Investigational Site Doral, Florida, United States
View all 17 locations
View Trial Details
Completed

Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 mg/g Compared to Delgocitinib Cream Vehicle Over an 8-week Treatment Period in Adult Subjects With Atopic Dermatitis.

NCT03725722

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Leo Pharma Investigational Site Birmingham, Alabama, United States
  • Leo Pharma Investigational Site Encino, California, United States
  • Leo Pharma Investigational Site Los Angeles, California, United States
  • Leo Pharma Investigational Site Los Angeles, California, United States
View all 31 locations
View Trial Details
Completed

Tralokinumab in Combination With Topical Corticosteroids for Moderate to Severe Atopic Dermatitis - ECZTRA 3

NCT03363854

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • University of Alabama-Birmingham Birmingham, Alabama, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • First OC Dermatology Fountain Valley, California, United States
  • Center for Dermatology Clinical Research Fremont, California, United States
View all 66 locations
View Trial Details
Completed

Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)

NCT03562377

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • Leo Pharma Investigational Site Fort Smith, Arkansas, United States
  • LEO Pharma Investigational Site Bakersfield, California, United States
  • Leo Pharma Investigational Site Beverly Hills, California, United States
  • Leo Pharma Investigational Site Fountain Valley, California, United States
View all 51 locations
View Trial Details
Completed

Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).

NCT03526861

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +9 more
Locations
  • LEO Pharma Investigational Site Birmingham, Alabama, United States
  • LEO Pharma Investigational Site Fort Smith, Arkansas, United States
  • Leo Pharma Investigational Site Fountain Valley, California, United States
  • LEO Pharma Investigational Site Los Angeles, California, United States
View all 87 locations
View Trial Details

Related conditions